Cris Bergerot, PhD
banner
crisbergerot.bsky.social
Cris Bergerot, PhD
@crisbergerot.bsky.social
Advancing oncology care through research, innovation, and multidisciplinary collaboration. Passionate about patient-centered solutions, PROs, HRQOL, and evidence-based practices, w a focus on #GUOnc, #GeriOnc & #PallOnc

#ASCO25 FCOI: http://bit.ly/344gKxq
Pinned
🚨New @ascocancer.bsky.social Guideline Alert! 🌍
Honored to have worked alongside #EnriqueSoto & cols in developing this guideline

Check out the latest recommendations on GA, designed to improve care worldwide

📄Full guideline ascopubs.org/doi/pdf/10.1...

🎙️Don’t miss the accompanying podcast!
Reposted by Cris Bergerot, PhD
Anytime we can join @chadinabhan.bsky.social for
a special #HealthcareUnfiltered episode, we're all in. I was pleased to join @shaalanbeg.bsky.social & @shrutipatelmd.bsky.social to highlight data from @ascocancer.bsky.social #GI26

Listen or watch the #podcast:
podcasts.apple.com/us/podcast/e...
Episode 265: ASCO GI Updates: Special Episode
Podcast Episode · Healthcare Unfiltered · 02/05/2026 · 58m
podcasts.apple.com
February 6, 2026 at 1:40 PM
Reposted by Cris Bergerot, PhD
IPOS Webinar Recording Now Available.

As part of World Cancer Day 2026, IPOS hosted a webinar on February 4 to spotlight the key findings from the Lancet Oncology Commission report, “The Human Crisis in Cancer.”

For information and to purchase the recording ipos-society.org/event-6556328
February 6, 2026 at 2:29 PM
Reposted by Cris Bergerot, PhD
It’s the story of a group of experts, who are bringing insights on the latest science...

Announcing our lineup of experts who'll serve as #GU26 Featured Voices, sharing which abstracts they’re most interested in, putting the findings into context & taking you along for the journey.
February 4, 2026 at 6:00 PM
Reposted by Cris Bergerot, PhD
2026 IS HERE – IPOS is accepting new members and renewals for 2026!

Being a member of IPOS means the opportunity to engage with professionals from 124 countries.

If you have already joined/renewed for 2026, THANK YOU! If you have not, NOW IS THE TIME! ipos-society.org/membership/a...
February 5, 2026 at 3:55 PM
Reposted by Cris Bergerot, PhD
The 2026 NCCN Guidelines for Patients are now available.

These guidelines provide trusted, patient-friendly information to help people understand kidney cancer diagnosis and treatment options.

You can now find the updated guidelines at www.patients.kidneycan.org

#AcceleratingCures
February 4, 2026 at 8:15 PM
Reposted by Cris Bergerot, PhD
The path to optimal cancer care is a shared one. As we recognize #WorldCancerDay, ASCO CMO Dr. @jrgralow.bsky.social reflects on the importance of trust, engagement, and empowerment in the patient journey.

Read in @@usatoday.com: https://bit.ly/3ZVeV2J
#UnitedByUnique
February 4, 2026 at 4:00 PM
Reposted by Cris Bergerot, PhD
Happening soon:
The "Best of SWOG" online research showcase.
Catch up on some of the most notable @swog.org research results from the past year.
Hope to see you there! #SWOGonc

Register for this one-hour event:
tinyurl.com/598z654w
January 28, 2026 at 5:26 PM
Reposted by Cris Bergerot, PhD
Join IPOS for World Cancer Day 2026: A Special Webinar on “The Human Crisis in Cancer” on February 4 from 8 to 9:30 a.m. ET. This is a live webcast and is open to all for FREE!

Almost 300 registrations received. Have you registered yet? www.ipos-society.org/event-6480465
January 28, 2026 at 7:12 PM
Reposted by Cris Bergerot, PhD
We’re excited to share our newly updated Patient Resource Center!

Created with input from patients, caregivers, & medical experts, it brings together clear, trusted information to help you navigate #KidneyCancer with confidence.

Explore what’s new at www.patients.kidneycan.org

#AcceleratingCures
January 29, 2026 at 1:29 PM
Reposted by Cris Bergerot, PhD
When the System Is the Treatment: Rethinking Nonpharmacologic Breakthroughs in Oncology
Congratulations @rsedhom.bsky.social & colleagues! @pallonccop.bsky.social ascopubs.org/doi/full/10....
When the System Is the Treatment: Rethinking Nonpharmacologic Breakthroughs in Oncology
ascopubs.org
January 21, 2026 at 7:04 PM
Reposted by Cris Bergerot, PhD
Happy New Year to all our followers. Mark your calendars for our first meeting of 2026, next Tuesday, with @linda-e-carlson.bsky.social and Sarah Bokovitz. DM for link and to be added to our mailing list.

@realbowtiedoc.bsky.social
@darcyburbage.bsky.social
@ascocancer.bsky.social #pallsky
January 13, 2026 at 4:52 PM
Reposted by Cris Bergerot, PhD
Only three days left to vote in the ASCO Election! The voting period closes Monday, December 8, 2025, at 3:00 PM (ET), and all ballots must be received by that time. Eligible members are encouraged to learn more about each candidate and then make your voice heard at: www.asco.org/about-asco/a... 🗳️
December 5, 2025 at 9:08 PM
Reposted by Cris Bergerot, PhD
Join us #tomorrow 4p EST to hear Dr Tamryn Gray speak about #family centered caregiving as well as an update in #policy through the implementation of the #CARE act. DM for a link. #pallonc

@crisbergerot.bsky.social
@realbowtiedoc.bsky.social
@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
November 18, 2025 at 9:08 AM
Reposted by Cris Bergerot, PhD
Day one of #COSAIPOS2025 is almost done! What a great day.

Are you here? Make sure you come visit the IPOS and COSA lounge!
November 12, 2025 at 7:10 AM
Reposted by Cris Bergerot, PhD
A letter to the editor discusses use of Olanzapine in cancer-associated cachexia, reporting possible short-term improvements in weight/appetite but raising uncertainty about long-term efficacy, risks and optimal patient selection.

pubmed.ncbi.nlm.nih.gov/41213247/
Letter to the Editor: Olanzapine for Cachexia-Short-Term Benefit, Long-Term Questions - PubMed
Letter to the Editor: Olanzapine for Cachexia-Short-Term Benefit, Long-Term Questions
pubmed.ncbi.nlm.nih.gov
November 13, 2025 at 7:26 AM
Reposted by Cris Bergerot, PhD
Voting in the ASCO Election is open now until December 8! Meet the candidate for President-Elect, Deborah Schrag, MD, MPH, FASCO.

Learn more about Dr. Schrag and make your voice heard at: brnw.ch/21wXn9K
November 10, 2025 at 9:09 PM
Reposted by Cris Bergerot, PhD
To be in the company of @mikkaelsekeres.bsky.social @crisbergerot.bsky.social is wild! Congrats to my fellow Fellows. I am so honored to be in your company and to be recognized by @ASCO
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO.

Learn more about FASCO distinction: brnw.ch/21wX0Hi
October 29, 2025 at 6:12 AM
Reposted by Cris Bergerot, PhD
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO.

Learn more about FASCO distinction: brnw.ch/21wX0Hi
October 28, 2025 at 8:29 PM
Reposted by Cris Bergerot, PhD
💚 As we close out #ASCOQLTY25, we are grateful to all of our attendees, in person and online, for being a part of the conversation as we work together to make progress in the quality, safety, and efficiency of #CancerCare delivery.
October 11, 2025 at 9:37 PM
Reposted by Cris Bergerot, PhD
Join us this Thursday to hear the highlights from #ASCOQLTY25 with #ASCOQLTY Chair Elect
@ryannipp.bsky.social

DM for the link or to be added to our mailing list.
@realbowtiedoc.bsky.social
@crisbergerot.bsky.social
@ericroeland.bsky.social
@fionnualacrowley.bsky.social

#pallonc
October 21, 2025 at 3:55 PM
Reposted by Cris Bergerot, PhD
For #NSCLC patients, socio-demographics better predict distress levels than metastatic status—challenging common assumptions in psych-oncology.

#ASCOQLTY25 #LungCancer #PsychosocialSupport
www.CancerSupportCommunity.org

Poster:
www.cancersupportcommunity.org/sites/defaul...
October 11, 2025 at 5:14 PM
Reposted by Cris Bergerot, PhD
💕 A big “thank you” to our #ASCOQLTY25 Featured Voices! Their expertise and insights are invaluable. We're so lucky to have them!

@fumikochino.bsky.social @crisbergerot.bsky.social @ryannipp.bsky.social
October 11, 2025 at 2:33 PM
Reposted by Cris Bergerot, PhD
October 10, 2025 at 3:31 PM
Reposted by Cris Bergerot, PhD
Great energy & dialogue in NYC this week during UN General Assembly & today’s High-level meeting on Non-Communicable Diseases & Mental Health. Working in collaboration we can (and must) accelerate efforts to improve outcomes in cancer & all NCDs globally. #UNGA2025 @ascocancer.bsky.social
September 25, 2025 at 3:37 PM